Corcept Therapeutics | CORT - 销售收入



金融业
股票价格
USD
资产
USD 888.7M
现金及等价物
USD 111.04M
销售成本
USD 4.06M
流动资产
USD 439.68M
流动负债
USD 153.8M
债务
USD 9.64M
EBIT
USD 41.3M
EBITDA
USD -49M
员工
500
EPS每股收益
USD 0.36
股本和储备
USD 705.78M
销售毛利
USD 252.09M
债务利息支出
USD 888.7M
利息收入
USD 4.89M
市值
USD 11.5B
净收入
USD 42.14M
营业费用
USD 214.85M
营业利润
USD 41.3M
普通股股本
USD 107.33M
PE价格收益
188.23
税前利润
USD -44.72M
销售收入
USD 256.15M
销售和管理费用
USD 156.9M
股票
USD 13.19M
贸易债权人
USD 14.91M
应收帐款人
USD 76.92M


销售 更改 日
Acadia Pharmaceuticals USD 307.96M 39.9M 2026-06
Alaunos Therapeutics USD 2K 2K 2025-03
ANI Pharmaceuticals USD 237.5M 9.56M 2026-03
Ardelyx USD 94.47M 30.74M 2026-03
Aurora Cannabis CAD 38.01M 56.18M 2026-03
BioMarin Pharmaceutical USD 766M 109M 2026-03
Bristol-Myers Squibb USD 12.97B 1.48B 2026-06
Canopy Growth CAD 71.25M 3.29M 2026-03
Corcept Therapeutics USD 256.15M 91.25M 2026-06
Eli Lilly USD 19.8B 500M 2026-03
J&J USD 25.31B 1.21B 2026-06
Knight Therapeutics CAD 133.11M 11.56M 2025-12
Lexicon Pharmaceuticals USD 5.49M 8.69M 2025-12
Merck USD 16.6B 310M 2026-06
Nektar Therapeutics USD 10.86M 10.95M 2026-03
Novartis USD 14.41B 1.3B 2026-06
Novartis USD 13.11B 750M 2026-03
Pacira USD 192.4M 15.4M 2026-06
Pfizer USD 15.03B 530M 2026-06
Supernus Pharmaceuticals USD 219.1M 11.39M 2026-06
TG Therapeutics USD 240.34M 45.54M 2026-06